Sandoz

Sandoz

featured image of Evotec and Sandoz Join Forces for Biosimilar Breakthrough
Companies

Evotec and Sandoz Join Forces for Biosimilar Breakthrough

BIOT

📢 Just – Evotec Biologics expands partnership with Sandoz, providing biosimilars and enhancing patient access. 🧪🤝 BiosimilarDevelopment

featured image of Sandoz Acquires Lucentis for $170 Million Boosting Ophthalmology Portfolio and Expanding Global Access
Companies

Sandoz Acquires Lucentis for $170 Million Boosting Ophthalmology Portfolio and Expanding Global Access

BIOT

📰 Sandoz acquires Coherus' Lucentis for $170m, expanding its ophthalmology portfolio. 💰 Lucentis treats eye diseases worldwide.

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact